TURKISH JOURNAL OF MEDICAL SCIENCES, vol.47, no.3, pp.841-846, 2017 (SCI-Expanded)
Background/aim: This study aimed to evaluate the role of adjuvant therapy for stage I uterine leiomyosarcoma (LMS).